An economic and cost-utility analysis of occupational therapy intervention after stroke

被引:0
|
作者
Logan, P. A. [1 ]
Quinn, C. [1 ]
Walker, M. [1 ]
Elliott, R. A. [1 ]
Gladman, J. R. F. [1 ]
机构
[1] Univ Nottingham, Nottingham NG7 2RD, England
关键词
D O I
暂无
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
P99
引用
收藏
页码:167 / 167
页数:1
相关论文
共 50 条
  • [31] Fabry disease: A cost-utility analysis of enzyme replacement therapy
    Moore, D. F.
    Ries, M.
    Forget, E.
    Schiffmann, R.
    ACTA PAEDIATRICA, 2007, 96 : 96 - 97
  • [32] Cost-utility analysis of a dance intervention for adolescent girls with internalizing problems
    Philipsson A.
    Duberg A.
    Möller M.
    Hagberg L.
    Cost Effectiveness and Resource Allocation, 11 (1)
  • [33] A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus
    Inadomi, John M.
    Somsouk, M. A.
    Madanick, Ryan D.
    Thomas, Jennifer P.
    Shaheen, Nicholas J.
    GASTROENTEROLOGY, 2009, 136 (07) : 2101 - 2114
  • [34] Cost-utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke - A Canadian healthcare perspective
    Sinclair, SE
    Frighetto, L
    Loewen, PS
    Sunderji, R
    Teal, P
    Fagan, SC
    Marra, CA
    PHARMACOECONOMICS, 2001, 19 (09) : 927 - 936
  • [35] Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis
    Elliott, Jesse
    McCoy, Blathnaid
    Clifford, Tammy
    Potter, Beth K.
    Wells, George A.
    Coyle, Doug
    PHARMACOECONOMICS, 2020, 38 (09) : 971 - 980
  • [36] Cost-utility analysis of shoulder arthroplasty: A Swiss health economic study
    Glanzmann, Michael
    Grobet, Cecile
    Eichler, Klaus
    Meier, Flurina
    Rickenbacher, Dominik
    Brunner, Beatrice
    Audige, Laurent
    SWISS MEDICAL WEEKLY, 2019, 149 : 2S - 2S
  • [37] Economic evaluation of mental health interventions: an introduction to cost-utility analysis
    Luyten, Jeroen
    Naci, Huseyin
    Knapp, Martin
    EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (02) : 49 - 53
  • [38] Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis
    Jesse Elliott
    Bláthnaid McCoy
    Tammy Clifford
    Beth K. Potter
    George A. Wells
    Doug Coyle
    PharmacoEconomics, 2020, 38 : 971 - 980
  • [39] COST-UTILITY OF APIXABAN FOR SECONDARY STROKE PREVENTION IN BRAZIL
    Diegoli, H.
    Makdisse, M.
    Moro, C. H. C.
    Longo, A. L.
    Franca, P. H. C.
    Magalhaes, P.
    VALUE IN HEALTH, 2023, 26 (12) : S111 - S111
  • [40] COST-UTILITY OF IN-AMBULANCE TELEMEDICINE FOR STROKE PATIENTS
    Espinoza, Valenzuela A.
    Devos, S.
    Van Hooff, R.
    Fobelets, M.
    Dupont, A.
    Brouns, R.
    Putman, K.
    VALUE IN HEALTH, 2016, 19 (07) : A699 - A699